Back to 
OSAIC HOLDINGS, INC.WEWEK
OSAIC HOLDINGS, INC.WEWEKShowing 0 of 17 quarters
Position history for OSAIC HOLDINGS, INC.'s holdings in ZIOPHARM ONCOLOGY INC
As of its Q4 2023 13F, Osaic held 556,666 shares of WEK (Ziopharm Oncology), worth $39,354. Osaic's 13F filings listed WEK from Q1 2020 to Q4 2023, 16 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of WEK: MSD Partners, L.P., MILLER VALUE PARTNERS, LLC